Genetic Screening Testing for Preventive Health Market
完整報告名稱與涵蓋範圍
Genetic Screening Testing for Preventive Health Market Size, Share & Trends Analysis Report By test type (Carrier Screening Tests (Expanded Carrier Screening, Targeted Carrier Screening), Non-Invasive Prenatal Tests, Preimplantation Genetic Testing, And Newborn Screening), Technology (NGS, Microarray, PCR, FISH), Application (Oncology, Cardiovascular Diseases, Reproductive Health, Neurodegenerative Health, Rare Diseases), And End-User (Hospitals And Diagnostic Laboratories, Dtc Companies, Genetic Counselling Services), By Region, And By Segment Forecasts, 2025-2034.
報告摘要
Across the 2025 to 2034 projection horizon, the worldwide Genetic Screening Testing for Preventive Health Market is poised to register a CAGR of 11.8%.
Genetic Screening Testing for Preventive Health covers reshaping how healthcare entities approach this space.
Market momentum is fueled by growing requirement advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Genetic Screening Testing for Preventive Health Market Snapshot
Chapter 4. Global Genetic Screening Testing for Preventive Health Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Genetic Screening Testing for Preventive Health Market Industry Trends
4.10. Global Genetic Screening Testing for Preventive Health Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Genetic Screening Testing for Preventive Health Market Segmentation 1: By Test Type, Estimates & Trend Analysis
5.1. Market Share By Test Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Test Type:
5.2.1. Carrier Screening Test
5.2.1.1. Expanded Carrier Screening
5.2.1.2. Targeted Carrier Screening
5.2.2. Non-Invasive Prenatal Test
5.2.3. Preimplantation Genetic Testing
5.2.4. Newborn Screening
Chapter 6. Genetic Screening Testing for Preventive Health Market Segmentation 2: By Technology, Estimates & Trend Analysis
6.1. Market Share By Technology, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:
6.2.1. NGS
6.2.2. Microarray
6.2.3. PCR
6.2.4. FISH
6.2.5. Others
Chapter 7. Genetic Screening Testing for Preventive Health Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share By Application, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
7.2.1. Oncology
7.2.2. Cardiovascular Diseases
7.2.3. Reproductive Health
7.2.4. Neurodegenerative Health
7.2.5. Rare Diseases
7.2.6. Others
Chapter 8. Genetic Screening Testing for Preventive Health Market Segmentation 4: By End User, Estimates & Trend Analysis
8.1. Market Share By End User, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
8.2.1. Hospitals and Diagnostic Laboratories
8.2.2. DTC Companies
8.2.3. Genetic Counselling Services
8.2.4. Other End Users
Chapter 9. Genetic Screening Testing for Preventive Health Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Genetic Screening Testing for Preventive Health Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Test Type, 2021-2034
9.2.3. North America Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Technology, 2021-2034
9.2.4. North America Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
9.2.5. North America Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
9.3. Europe
9.3.1. Europe Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Test Type, 2021-2034
9.3.3. Europe Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Technology, 2021-2034
9.3.4. Europe Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
9.3.5. Europe Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Test Type, 2021-2034
9.4.3. Asia Pacific Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Technology, 2021-2034
9.4.4. Asia Pacific Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
9.4.5. Asia Pacific Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
9.5. Latin America
9.5.1. Latin America Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Test Type, 2021-2034
9.5.3. Latin America Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Technology, 2021-2034
9.5.4. Latin America Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
9.5.5. Latin America Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Test Type, 2021-2034
9.6.3. Middle East & Africa Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Technology, 2021-2034
9.6.4. Middle East & Africa Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
9.6.5. Middle East & Africa Genetic Screening Testing for Preventive Health Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Exact Science
10.2.1.1. Business Overview
10.2.1.2. Key Product Type/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Labcorp Genetics Inc.
10.2.3. Blueprint Genetics
10.2.4. Ambry Genetics
10.2.5. Genex Diagnostics Inc.
10.2.6. Sonic Healthcare
10.2.7. Dante Labs US
10.2.8. Myriad Genetics, Inc.
10.2.9. Revvity
10.2.10. Laboratory Corporation of America Holdings
10.2.11. 23andMe
10.2.12. BGI Group
10.2.13. CENTOGENE N.V.
10.2.14. Fulgent Genetics.
10.2.15. Quest Diagnostics Incorporated.
10.2.16. Progenesis
10.2.17. CooperSurgical
10.2.18. Illumina
10.2.19. Igenomix
10.2.20. Agilent Technologies, Inc.
10.2.21. Other Key Companies
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們